Where next for AstraZeneca stock ahead of Q1 2022 earnings
AstraZeneca’s results will benefit from the acquisition of Alexion, but questions remain over its Covid-19 drugs and the outlook in China.
Source: cityindex.co.uk
Stay updated with breaking news from Mzn Technical Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AstraZeneca’s results will benefit from the acquisition of Alexion, but questions remain over its Covid-19 drugs and the outlook in China.
Markets believe AstraZeneca can continue to deliver strong double-digit growth in 2022, but will the pharma giant’s outlook meet expectations this week?
Amazon shares have lost over 12% in value since the start of the year, but can its upcoming earnings provide a catalyst for it to recover?